Feifang Hu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Feifang Hu has a total of 36 co-authors. Here are the top co-authors by number of shared publications:
Wei Ma
Institute of Statistics and Big Data Renmin University of China Beijing China
6 shared publications- Wei Ma
Institute of Statistics and Big Data Renmin University of China Beijing China
4 shared publications Li-Xin Zhang
Center for Data Science and School of Mathematical Sciences, Zhejiang University, Hangzhou, China
3 shared publications- Li-Xin Zhang
School of Mathematical Sciences, Zhejiang University, Hangzhou, P. R. China
3 shared publications Yang Li
3 shared publicationsYang Liu
Institute of Statistics and Big Data, Renmin University of China
3 shared publications
Latest Publications
- 6 October 2026
- Published by Taylor & Francis in Journal of the American Statistical Association
- p. 1-105
Statistical Inference with Mixed-Effect Model for Covariate-Adaptive Randomized Experiments
1 IntroductionIn clinical trials, A/B tests, and economic studies, covariate-adaptive randomization (CAR) is widely used to balance important baseline covariates across different treatment arms (Br...
- 6 October 2026
- Published by Taylor & Francis in Journal of the American Statistical Association
- p. 1-105
Statistical Inference with Mixed-Effect Model for Covariate-Adaptive Randomized Experiments
1 IntroductionIn clinical trials, A/B tests, and economic studies, covariate-adaptive randomization (CAR) is widely used to balance important baseline covariates across different treatment arms (Br...
- 30 July 2025
- Published by SAGE Publications in Statistical Methods in Medical Research
- Vol. 34 (9) , 1886-1898
Efficient randomized adaptive designs for multi-arm clinical trials
In clinical trials, response-adaptive randomization (RAR) has gained increasing attention due to its ability to assign more patients to better-performing treatments. Consequently, several RAR methods have been proposed in recent years. Among them, the efficient response adaptive randomization design (ERADE), proposed by Hu et al. (2009), stands out as an optimal approach, with the asymptotic variance of the allocation proportion achieving the Cramér–Rao lower bound, demonstrating its statistical efficiency. However, the original ERADE is limited to trials with only two treatment arms. Given the growing prevalence of multi-arm trials in modern clinical development, the original ERADE design no longer meets all practical needs. In this paper, we extend ERADE for use in multi-arm clinical trials, proposing the multi-arm ERADE algorithm. We establish the asymptotic properties of this generalized design and demonstrate its effectiveness in finite sample settings through simulations and a real-world trial redesign.
- 30 July 2025
- Published by SAGE Publications in Statistical Methods in Medical Research
- Vol. 34 (9) , 1886-1898
Efficient randomized adaptive designs for multi-arm clinical trials
In clinical trials, response-adaptive randomization (RAR) has gained increasing attention due to its ability to assign more patients to better-performing treatments. Consequently, several RAR methods have been proposed in recent years. Among them, the efficient response adaptive randomization design (ERADE), proposed by Hu et al. (2009), stands out as an optimal approach, with the asymptotic variance of the allocation proportion achieving the Cramér–Rao lower bound, demonstrating its statistical efficiency. However, the original ERADE is limited to trials with only two treatment arms. Given the growing prevalence of multi-arm trials in modern clinical development, the original ERADE design no longer meets all practical needs. In this paper, we extend ERADE for use in multi-arm clinical trials, proposing the multi-arm ERADE algorithm. We establish the asymptotic properties of this generalized design and demonstrate its effectiveness in finite sample settings through simulations and a real-world trial redesign.
- 2 April 2025
- Published by Oxford University Press (OUP) in Biometrics
- Vol. 81 (2)
Statistical inference on the relative risk following covariate-adaptive randomization
Covariate-adaptive randomization (CAR) is widely adopted in clinical trials to ensure balanced treatment allocations across key baseline covariates. Although much research has focused on analyzing average treatment effects, the inference of relative risk under CAR experiments has been less thoroughly explored. In this study, we examine a covariate-adjusted estimate of relative risk and investigate the properties of its associated hypothesis tests under CAR. We first derive the theoretical properties of the covariate-adjusted relative risk for a broad class of CAR procedures. Our findings indicate that conventional tests for relative risk tend to be conservative, leading to reduced type I error rates. To mitigate this issue, we introduce model-based and model-robust methods that enhance the estimation of standard errors. We demonstrate the validity and usage of model-robust and model-based adjusted tests. Extensive numerical studies have been conducted to demonstrate our theoretical findings and the favorable properties of the proposed adjustment methods.
- 2 April 2025
- Published by Oxford University Press (OUP) in Biometrics
- Vol. 81 (2)
Statistical inference on the relative risk following covariate-adaptive randomization
Covariate-adaptive randomization (CAR) is widely adopted in clinical trials to ensure balanced treatment allocations across key baseline covariates. Although much research has focused on analyzing average treatment effects, the inference of relative risk under CAR experiments has been less thoroughly explored. In this study, we examine a covariate-adjusted estimate of relative risk and investigate the properties of its associated hypothesis tests under CAR. We first derive the theoretical properties of the covariate-adjusted relative risk for a broad class of CAR procedures. Our findings indicate that conventional tests for relative risk tend to be conservative, leading to reduced type I error rates. To mitigate this issue, we introduce model-based and model-robust methods that enhance the estimation of standard errors. We demonstrate the validity and usage of model-robust and model-based adjusted tests. Extensive numerical studies have been conducted to demonstrate our theoretical findings and the favorable properties of the proposed adjustment methods.
- 25 November 2024
- Published by Wiley in Statistics in Medicine
- Vol. 43 (30) , 5911-5921
Response‐Adaptive Randomization Procedure in Clinical Trials with Surrogate Endpoints
In clinical trials, subjects are usually recruited sequentially. According to the outcomes amassed thus far in a trial, the response‐adaptive randomization (RAR) design has been shown to be an advantageous treatment assignment procedure that skews the treatment allocation proportion to pre‐specified objectives, such as sending more patients to a more promising treatment. Unfortunately, there are circumstances under which very few data of the primary endpoints are collected in the recruitment period, such as circumstances relating to public health emergencies and chronic diseases, and RAR is thus difficult to apply in allocating treatments using available outcomes. To overcome this problem, if an informative surrogate endpoint can be acquired much earlier than the primary endpoint, the surrogate endpoint can be used as a substitute for the primary endpoint in the RAR procedure. In this paper, we propose an RAR procedure that relies only on surrogate endpoints. The validity of the statistical inference on the primary endpoint and the patient benefit of this approach are justified by both theory and simulation. Furthermore, different types of surrogate endpoint and primary endpoint are considered. The results reassure that RAR with surrogate endpoints can be a viable option in some cases for clinical trials when primary endpoints are unavailable for adaptation.
- 25 November 2024
- Published by Wiley in Statistics in Medicine
- Vol. 43 (30) , 5911-5921
Response‐Adaptive Randomization Procedure in Clinical Trials with Surrogate Endpoints
In clinical trials, subjects are usually recruited sequentially. According to the outcomes amassed thus far in a trial, the response‐adaptive randomization (RAR) design has been shown to be an advantageous treatment assignment procedure that skews the treatment allocation proportion to pre‐specified objectives, such as sending more patients to a more promising treatment. Unfortunately, there are circumstances under which very few data of the primary endpoints are collected in the recruitment period, such as circumstances relating to public health emergencies and chronic diseases, and RAR is thus difficult to apply in allocating treatments using available outcomes. To overcome this problem, if an informative surrogate endpoint can be acquired much earlier than the primary endpoint, the surrogate endpoint can be used as a substitute for the primary endpoint in the RAR procedure. In this paper, we propose an RAR procedure that relies only on surrogate endpoints. The validity of the statistical inference on the primary endpoint and the patient benefit of this approach are justified by both theory and simulation. Furthermore, different types of surrogate endpoint and primary endpoint are considered. The results reassure that RAR with surrogate endpoints can be a viable option in some cases for clinical trials when primary endpoints are unavailable for adaptation.
- 16 September 2024
- Published by Wiley in Statistics in Medicine
- Vol. 43 (27) , 5047-5059
Group Response‐Adaptive Randomization With Delayed and Missing Responses
Response‐adaptive randomization (RAR) procedures have been extensively studied in the literature, but most of the procedures rely on updating the randomization after each response, which is impractical in many clinical trials. In this article, we propose a new family of RAR procedures that dynamically update based on the responses of a group of individuals, either when available or at fixed time intervals (weekly or biweekly). We show that the proposed design retains the essential theoretical properties of Hu and Zhang's doubly adaptive biased coin designs (DBCD), and performs well in scenarios involving delayed and randomly missing responses. Numerical studies have been conducted to demonstrate that the new proposed group doubly adaptive biased coin design has similar properties to the Hu and Zhang's DBCDs in different situations. We also apply the new design to a real clinical trial, highlighting its advantages and practicality. Our findings open the door to studying the properties of other group response adaptive designs, such as urn models, and facilitate the application of response‐adaptive randomized clinical trials in practice.
- 16 September 2024
- Published by Wiley in Statistics in Medicine
- Vol. 43 (27) , 5047-5059
Group Response‐Adaptive Randomization With Delayed and Missing Responses
Response‐adaptive randomization (RAR) procedures have been extensively studied in the literature, but most of the procedures rely on updating the randomization after each response, which is impractical in many clinical trials. In this article, we propose a new family of RAR procedures that dynamically update based on the responses of a group of individuals, either when available or at fixed time intervals (weekly or biweekly). We show that the proposed design retains the essential theoretical properties of Hu and Zhang's doubly adaptive biased coin designs (DBCD), and performs well in scenarios involving delayed and randomly missing responses. Numerical studies have been conducted to demonstrate that the new proposed group doubly adaptive biased coin design has similar properties to the Hu and Zhang's DBCDs in different situations. We also apply the new design to a real clinical trial, highlighting its advantages and practicality. Our findings open the door to studying the properties of other group response adaptive designs, such as urn models, and facilitate the application of response‐adaptive randomized clinical trials in practice.
- 25 June 2024
- Published by Springer Nature
- p. 339-374
Adaptive Designs for Precision Medicine in Clinical Trials: A Review and Some Innovative Designs
- 25 June 2024
- Published by Springer Nature
- p. 339-374
Adaptive Designs for Precision Medicine in Clinical Trials: A Review and Some Innovative Designs
- 27 March 2024
- Published by Oxford University Press (OUP) in Biometrics
- Vol. 80 (2)
Robustness of response-adaptive randomization
Doubly adaptive biased coin design (DBCD), a response-adaptive randomization scheme, aims to skew subject assignment probabilities based on accrued responses for ethical considerations. Recent years have seen substantial advances in understanding DBCD’s theoretical properties, assuming correct model specification for the responses. However, concerns have been raised about the impact of model misspecification on its design and analysis. In this paper, we assess the robustness to both design model misspecification and analysis model misspecification under DBCD. On one hand, we confirm that the consistency and asymptotic normality of the allocation proportions can be preserved, even when the responses follow a distribution other than the one imposed by the design model during the implementation of DBCD. On the other hand, we extensively investigate three commonly used linear regression models for estimating and inferring the treatment effect, namely difference-in-means, analysis of covariance (ANCOVA) I, and ANCOVA II. By allowing these regression models to be arbitrarily misspecified, thereby not reflecting the true data generating process, we derive the consistency and asymptotic normality of the treatment effect estimators evaluated from the three models. The asymptotic properties show that the ANCOVA II model, which takes covariate-by-treatment interaction terms into account, yields the most efficient estimator. These results can provide theoretical support for using DBCD in scenarios involving model misspecification, thereby promoting the widespread application of this randomization procedure.
- 27 March 2024
- Published by Oxford University Press (OUP) in Biometrics
- Vol. 80 (2)
Robustness of response-adaptive randomization
Doubly adaptive biased coin design (DBCD), a response-adaptive randomization scheme, aims to skew subject assignment probabilities based on accrued responses for ethical considerations. Recent years have seen substantial advances in understanding DBCD’s theoretical properties, assuming correct model specification for the responses. However, concerns have been raised about the impact of model misspecification on its design and analysis. In this paper, we assess the robustness to both design model misspecification and analysis model misspecification under DBCD. On one hand, we confirm that the consistency and asymptotic normality of the allocation proportions can be preserved, even when the responses follow a distribution other than the one imposed by the design model during the implementation of DBCD. On the other hand, we extensively investigate three commonly used linear regression models for estimating and inferring the treatment effect, namely difference-in-means, analysis of covariance (ANCOVA) I, and ANCOVA II. By allowing these regression models to be arbitrarily misspecified, thereby not reflecting the true data generating process, we derive the consistency and asymptotic normality of the treatment effect estimators evaluated from the three models. The asymptotic properties show that the ANCOVA II model, which takes covariate-by-treatment interaction terms into account, yields the most efficient estimator. These results can provide theoretical support for using DBCD in scenarios involving model misspecification, thereby promoting the widespread application of this randomization procedure.
- 1 January 2024
- Published by Statistica Sinica (Institute of Statistical Science) in Statistica Sinica
- Vol. 34 (1) , 353-375
Adaptive Randomization via Mahalanobis Distance
- 1 January 2024
- Published by Statistica Sinica (Institute of Statistical Science) in Statistica Sinica
- Vol. 34 (1) , 353-375
Adaptive Randomization via Mahalanobis Distance
- 20 September 2022
- Published by Taylor & Francis in Journal of the American Statistical Association
- Vol. 119 (545) , 151-162
A New and Unified Family of Covariate Adaptive Randomization Procedures and Their Properties
In clinical trials and other comparative studies, covariate balance is crucial for credible and efficient assessment of treatment effects. Covariate adaptive randomization (CAR) procedures are extensively used to reduce the likelihood of covariate imbalances occurring. In the literature, most studies have focused on balancing of discrete covariates. Applications of CAR with continuous covariates remain rare, especially when the interest goes beyond balancing only the first moment. In this article, we propose a family of CAR procedures that can balance general covariate features, such as quadratic and interaction terms. Our framework not only unifies many existing methods, but also introduces a much broader class of new and useful CAR procedures. We show that the proposed procedures have superior balancing properties; in particular, the convergence rate of imbalance vectors is for any if all of the moments are finite for the covariate features, relative to under complete randomization, where n is the sample size. Both the resulting convergence rate and its proof are novel. These favorable balancing properties lead to increased precision of treatment effect estimation in the presence of nonlinear covariate effects. The framework is applied to balance covariate means and covariance matrices simultaneously. Simulation and empirical studies demonstrate the excellent and robust performance of the proposed procedures. Supplementary materials for this article are available online.- 20 September 2022
- Published by Taylor & Francis in Journal of the American Statistical Association
- Vol. 119 (545) , 151-162
A New and Unified Family of Covariate Adaptive Randomization Procedures and Their Properties
In clinical trials and other comparative studies, covariate balance is crucial for credible and efficient assessment of treatment effects. Covariate adaptive randomization (CAR) procedures are extensively used to reduce the likelihood of covariate imbalances occurring. In the literature, most studies have focused on balancing of discrete covariates. Applications of CAR with continuous covariates remain rare, especially when the interest goes beyond balancing only the first moment. In this article, we propose a family of CAR procedures that can balance general covariate features, such as quadratic and interaction terms. Our framework not only unifies many existing methods, but also introduces a much broader class of new and useful CAR procedures. We show that the proposed procedures have superior balancing properties; in particular, the convergence rate of imbalance vectors is for any if all of the moments are finite for the covariate features, relative to under complete randomization, where n is the sample size. Both the resulting convergence rate and its proof are novel. These favorable balancing properties lead to increased precision of treatment effect estimation in the presence of nonlinear covariate effects. The framework is applied to balance covariate means and covariance matrices simultaneously. Simulation and empirical studies demonstrate the excellent and robust performance of the proposed procedures. Supplementary materials for this article are available online.- 21 July 2022
- Published by Springer Nature in Science China Mathematics
- Vol. 66 (1) , 163-190
Multi-arm covariate-adaptive randomization
Simultaneously investigating multiple treatments in a single study achieves considerable efficiency in contrast to the traditional two-arm trials. Balancing treatment allocation for influential covariates has become increasingly important in today’s clinical trials. The multi-arm covariate-adaptive randomized clinical trial is one of the most powerful tools to incorporate covariate information and multiple treatments in a single study. Pocock and Simon’s procedure has been extended to the multi-arm case. However, the theoretical properties of multi-arm covariate-adaptive randomization have remained largely elusive for decades. In this paper, we propose a general framework for multi-arm covariate-adaptive designs which also includes the two-arm case, and establish the corresponding theory under widely satisfied conditions. The theoretical results provide new insights about balance properties of covariate-adaptive randomization procedures and make foundations for most existing statistical inferences under two-arm covariate-adaptive randomization. Furthermore, these open a door to study the theoretical properties of statistical inferences for clinical trials based on multi-arm covariate-adaptive randomization procedures.
- 21 July 2022
- Published by Springer Nature in Science China Mathematics
- Vol. 66 (1) , 163-190
Multi-arm covariate-adaptive randomization
Simultaneously investigating multiple treatments in a single study achieves considerable efficiency in contrast to the traditional two-arm trials. Balancing treatment allocation for influential covariates has become increasingly important in today’s clinical trials. The multi-arm covariate-adaptive randomized clinical trial is one of the most powerful tools to incorporate covariate information and multiple treatments in a single study. Pocock and Simon’s procedure has been extended to the multi-arm case. However, the theoretical properties of multi-arm covariate-adaptive randomization have remained largely elusive for decades. In this paper, we propose a general framework for multi-arm covariate-adaptive designs which also includes the two-arm case, and establish the corresponding theory under widely satisfied conditions. The theoretical results provide new insights about balance properties of covariate-adaptive randomization procedures and make foundations for most existing statistical inferences under two-arm covariate-adaptive randomization. Furthermore, these open a door to study the theoretical properties of statistical inferences for clinical trials based on multi-arm covariate-adaptive randomization procedures.